Mark Guinan
Director/Board Member en UPHEALTH, INC. .
Fortuna: 167 030 $ al 31/03/2024
Perfil
En la actualidad, Mark J. Guinan ocupa el cargo de director financiero y vicepresidente ejecutivo de Quest Diagnostics, Inc. El Sr. Guinan también forma parte del consejo de Myovant Sciences Ltd., Q Squared Solutions Holdings Ltd. y Roivant Sciences, Inc. Anteriormente ocupó el cargo de director financiero y vicepresidente senior de Hill-Rom Holdings, Inc., vicepresidente de finanzas de Global Pharmaceutical Group, director de compras de Johnson & Johnson y director de Procter & Gamble Co. Mark J. Guinan se licenció en la Universidad de Notre Dame y obtuvo un MBA en la Olin Business School.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
UPHEALTH INC
0.86% | 31/01/2024 | 160 606 ( 0.86% ) | 167 030 $ | 31/03/2024 |
Cargos activos de Mark Guinan
Empresas | Cargo | Inicio |
---|---|---|
UPHEALTH, INC. | Director/Board Member | 05/12/2022 |
Q Squared Solutions Holdings Ltd.
Q Squared Solutions Holdings Ltd. Medical/Nursing ServicesHealth Services Part of IQVIA Holdings, Inc., Q Squared Solutions Holdings Ltd. is a British company that provides health services. The private company is based in Reading, UK. | Director/Board Member | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director/Board Member | - |
Antiguos cargos conocidos de Mark Guinan.
Empresas | Cargo | Fin |
---|---|---|
MYOVANT SCIENCES LTD. | Director/Board Member | 10/03/2023 |
QUEST DIAGNOSTICS INCORPORATED | Director of Finance/CFO | 11/07/2022 |
HILL-ROM HOLDINGS, INC. | Director of Finance/CFO | 19/07/2013 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2010 |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Formación de Mark Guinan.
University of Notre Dame | Undergraduate Degree |
Olin Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
QUEST DIAGNOSTICS INCORPORATED | Health Services |
UPHEALTH, INC. | Health Services |
Empresas privadas | 5 |
---|---|
Hill-Rom Holdings, Inc.
Hill-Rom Holdings, Inc. Hospital/Nursing ManagementHealth Services Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL. | Health Services |
Global Pharmaceutical Group | |
Myovant Sciences Ltd.
Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Q Squared Solutions Holdings Ltd.
Q Squared Solutions Holdings Ltd. Medical/Nursing ServicesHealth Services Part of IQVIA Holdings, Inc., Q Squared Solutions Holdings Ltd. is a British company that provides health services. The private company is based in Reading, UK. | Health Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Guinan